The GLAUrious is clinically testing and validating the novel External Automatic Glaucoma Laser (EAGLE) device developed and patented by BELKIN Laser Ltd with the goal of providing accessible first-line treatment for glaucoma.
GLAUrious project aims to ease commercialization of the EAGLE device by securing clinical prototype validation, streamlining commercial production, optimizing component costs, disseminating to key opinion leaders and distributors, and refining commercial strategy.
The multidisciplinary GLAUrious Consortium is led by Queen's University Belfast (Northern Ireland, UK) consists of four additional partners- BELKIN Laser Ltd (Israel), Frankfurt Laser Company (Germany), MCI bvba (Belgium), Eye clinic University of Genova (Italy).
During the last year the advanced clinical prototype was produced and validated to meet the requirements of UK and Italian authorities’ towards prospective randomized clinical study initiation (trial registered at ISRCTN # 14033075).
We use cookies to offer you a better browsing experience, personalise content and ads, to provide social media features and to analyse our traffic. Read about how you can control cookie usage by clicking Settings. You consent to our cookies if you continue to use this website.
Please choose which type of cookies you consent to:
Website functionality(ie. account login related cookies) These cookies are necessary for the website to function and cannot be disabled in your systems. As a rule, these cookies are only set in response to actions you take that correspond to a service request, such as setting your privacy preferences. You can set your browser to block these cookies or to notify you about these cookies. These cookies do not store any personal data.
Connection to social networks(i.e. facebook) These cookies are set by a number of social media services that we use on the website to allow you to share our content with your friends and networks. These cookies are able to track your browser across other websites and build a profile of your interests. This may affect content and messages you see on other websites. If you do not allow these cookies, you may not be able to use or see these sharing tools.
Control of media content(i.e. youtube) These cookies are set by a number of multimedia services that we use on the Site. So that you can stop our content; Start; Turn louder and turn down. If you do not allow these cookies, you may not be able to view or operate videos.
Marketing issues(ie. Google Analytics) These cookies - also known as targeting cookies - may be set through our website by our advertising partners. They may be used by these companies to profile your interests and show you relevant ads on other websites. They do not directly store personal information, but are based on a unique identification of your browser and Internet device. If you do not allow these cookies, you will experience less targeted advertising.
Your cookie settings (accept or decline) will be stored on your computer to be considered during future visits to this site. You can change your settings by clicking the corresponding link on the privacy policy page.
The GLAUrious is clinically testing and validating the novel External Automatic Glaucoma Laser (EAGLE) device developed and patented by BELKIN Laser Ltd with the goal of providing accessible first-line treatment for glaucoma.